Top Industry Leaders in the Delirium Market
Latest Delirium Companies Updates:
Pfizer Continued marketing of Aricept (donepezil) for the treatment of delirium in dementia patients, emphasizing its safety and efficacy profile.
AstraZeneca Collaboration with the Delirium Consortium to develop and validate new diagnostic tools for delirium in critically ill patients.
Cognito Therapeutics Phase 2b clinical trial results for its investigational drug, CNT001, showed improvements in cognitive function and delirium symptoms in older adults with mild cognitive impairment.
Philips Healthcare Development of AI-powered vital sign monitoring systems to detect early signs of delirium in critically ill patients.
List of Delirium Key companies in the market:
- Otsuka Pharmaceutical Co., Ltd (Japan)
- Mylan N.V (US)
- Teva Pharmaceutical Industries Ltd (Israel)
- Zydus Group (India)
- Glenmark Pharmaceuticals Ltd (India)
- Pfizer (India)
- Mylan N.V (US)
- Teva Pharmaceutical Industries Ltd (Israel)
- Glenmark Pharmaceuticals Ltd (India)